MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway

Yang, Xin, Liang, Lei, Zhang, Xiao-Fei, Jia, Hu-Liang, Qin, Yi, Zhu, Xu-Chao, Gao, Xiao-Mei, Qiao, Peng +8 more·2013·Hepatology
DOI 10.1002/hep.26305

Cited by (280)

Items 101–200 of 280

  1. Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression.
    Chaoqun Wang, Haoting Sun, Xiaomei Gao, Ning Ren, Yuan‐Yuan Sheng, Zheng Wang, Yan Zheng, Jinwang Wei, Kaili Zhang, Xinxin Yu et al. · 2016 · PubMed Central
  2. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines
    Floriana Maria Farina, Alessandra Inguscio, Paolo Kunderfranco, Alice Cortesi, Leonardo Elia, Manuela Quintavalle · 2017 · Cell Death and Disease
  3. Integrated MicroRNA–mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A
    Sirjana Shrestha, Chi-Dung Yang, Hsiao-Chin Hong, Chih‐Hung Chou, Chun-San Tai, Men-Yee Chiew, Wenliang Chen, Shun-Long Weng, Chung-Chu Chen, Yi‐An Chang et al. · 2017 · International Journal of Molecular Sciences
  4. Intricate crosstalk between MYC and non‐coding RNA s regulates hallmarks of cancer
    Lotteke J. Y. M. Swier, Agnieszka Dzikiewicz‐Krawczyk, Melanie Winkle, Anke van den Berg, Joost L. Kluiver · 2018 · Molecular Oncology
  5. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
    Kurt Sartorius, Leo Swadling, Ping An, Julia Alekseevna Makarova, Cheryl Ann Winkler, Anil Amichund Chuturgoon, Anna Kramvis · 2020 · Viruses
  6. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation
    Xin Li, Ling Lian, Daixi Zhang, Lujiang Qu, Ning Yang · 2014 · Poultry Science
  7. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
    Hyo Jung Cho, Soon Sun Kim, Ji Sun Nam, Jai Keun Kim, Jei Hee Lee, Bohyun Kim, Hee-Jung Wang, Bong‐Wan Kim, Jung-Dong Lee, Dae Yong Kang et al. · 2016 · Clinics and Research in Hepatology and Gastroenterology
  8. MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1
    Xiaoyan Yang, Mei Dong, Hao Wen, Xiaoling Liu, Meng Zhang, Lianyue Ma, Cheng Zhang, Xiaorong Luan, Huixia Lu, Yun Zhang · 2017 · Oncotarget
  9. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis
    Bosheng He, Jianbing Yin, Shenchu Gong, Jin‐Hua Gu, Jing Xiao, Weixiang Shi, Wenbin Ding, Ying He · 2017 · Medicine
  10. Decreased MicroRNA-26a expression causes cisplatin resistance in human non-small cell lung cancer
    Yong Yang, Peng Zhang, Yanfeng Zhao, Jie Yang, Gening Jiang, Jie Fan · 2015 · Cancer Biology & Therapy
  11. mRNA and miRNA Regulatory Networks Reflective of Multi-Walled Carbon Nanotube-Induced Lung Inflammatory and Fibrotic Pathologies in Mice
    Julian Dymacek, Brandi N. Snyder‐Talkington, Dale W. Porter, Robert R. Mercer, Michael G. Wolfarth, Vincent Castranova, Yong Ri Qian, Nancy Lan Guo · 2014 · Toxicological Sciences
  12. Expression and prognostic value of microRNA‐26a and microRNA‐148a in gastric cancer
    Xiaonan Qiu, Haixia Zhu, Sang Liu, Guoquan Tao, Jing Jin, Haiyan Chu, Meilin Wang, Na Tong, Weida Gong, Qinghong Zhao et al. · 2016 · Journal of Gastroenterology and Hepatology
  13. miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival
    Ming Chen, Wei Hu, Chenling Xiong, Zhen Qu, Changqing Yin, Yu-Hui Wang, Changliang Luo, Qing Guan, Chunhui Yuan, Xinghuan Wang · 2016 · Oncotarget
  14. miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression
    Rui Chu, Guang-quan Mo, Zhijun Duan, Mei Huang, Jiuyang Chang, Xiaodong Li, Pixu Liu · 2014 · Cell Communication and Signaling
  15. A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma
    Chunbo Zhuang, Pei Wang, Da Huang, Luming Xu, Xiaobei Wang, Lin Wang, Lihua Hu · 2016 · International Journal of Oncology
  16. miR-4417 Targets Tripartite Motif-Containing 35 (TRIM35) and Regulates Pyruvate Kinase Muscle 2 (PKM2) Phosphorylation to Promote Proliferation and Suppress Apoptosis in Hepatocellular Carcinoma Cells
    Lijie Song, Weijie Zhang, Zhiwei Chang, Yanfeng Pan, Hong Zong, Qingxia Fan, Liuxing Wang · 2017 · Medical Science Monitor
  17. Delivery of miR-26a Using an Exosomes-Based Nanosystem Inhibited Proliferation of Hepatocellular Carcinoma
    Shaya Mahati, Xiangjun Fu, Xuexian Ma, Hua Zhang, Lei Xiao · 2021 · Frontiers in Molecular Biosciences
  18. A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells
    Chongqiang Zhao, Wenlong Wang, Wenying Yu, David Jou, Yina Wang, Haiyan Ma, Hui Xiao, Hua Qin, Cuntai Zhang, Jiagao Lü et al. · 2016 · Oncotarget
  19. MicroRNA-20a-5p targets RUNX3 to regulate proliferation and migration of human hepatocellular cancer cells
    Yanke Chen, Xiaofei Wang, Jiwen Cheng, Zhen Wang, Ting Jiang, Ni Hou, Na Liu, Tusheng Song, Chen Yu Huang · 2016 · Oncology Reports
  20. Identifying miRNA-mRNA Pairs and Novel miRNAs from Hepatocelluar Carcinoma miRNomes and TCGA Database
    Ping Wu, Yunyue Xiao, Tao Guo, Yitao Wang, Shanshan Liao, Lang Chen, Zhisu Liu · 2019 · Journal of Cancer
  21. Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma
    Huamin Wang, Xiaoping Su, Mingjin Yang, Taoyong Chen, Jin Hou, Nan Li, Xuetao Cao · 2015 · OncoImmunology
  22. MicroRNAs expression profiling in Egyptian colorectal cancer patients
    Noha G. Bader El Din, Marwa K. Ibrahim, Reem El‐Shenawy, Ghada Maher Salum, Sally Farouk, Naglaa Ali Zayed, Ahmed M. Khairy, Mostafa K. El Awady · 2019 · IUBMB Life
  23. CXCL10 accelerates EMT and metastasis by MMP-2 in hepatocellular carcinoma.
    Tingting Ren, Lili Zhu, Mingliang Cheng · 2017 · PubMed Central
  24. MiR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways
    Jinhui Wu, Yi-han Wang, Wei Wang, Wei Shen, Yanzhi Sang, Lin Liu, Cuimin Chen · 2016 · The International Journal of Biochemistry & Cell Biology
  25. MiR-26a performs converse roles in proliferation and metastasis of different gastric cancer cells via regulating of PTEN expression
    Keshuo Ding, Zhengsheng Wu, Nana Wang, Xiaonan Wang, Yuejun Wang, Pengxu Qian, Gang Meng, Sheng Hui Tan · 2017 · Pathology - Research and Practice
  26. Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
    Yue Zhang, Chao Wei, Congcong Guo, Rongxiu Bi, Jin Xie, Dong-Hui Guan, Chuan-Hua Yang, Yue-Hua Jiang · 2017 · Oncotarget
  27. The dual blockade of MET and VEGFR2 signaling demonstrates pronounced inhibition on tumor growth and metastasis of hepatocellular carcinoma
    Yu Zhang, Xiaomei Gao, Ying Zhu, Dhruba Kadel, Haoran Sun, Jing Chen, Qin Luo, Haoting Sun, Luyu Yang, Jing Yang et al. · 2018 · Journal of Experimental & Clinical Cancer Research
  28. miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2
    Wentao Zhao, Xiaolin Lin, Yu Liu, Liu-Xin Han, Jing Li, Taoyan Lin, Junwen Shi, Shengchun Wang, Mei Lian, Hengwei Chen et al. · 2019 · Laboratory Investigation
  29. Programmed cell senescence: role of IL-6 in the pituitary
    Melanie Sapochnik, Mariana Fuertes, EDUARDO S. ARZT · 2017 · Journal of Molecular Endocrinology
  30. Hepatitis B virus promotes cancer cell migration by downregulating miR-340-5p expression to induce STAT3 overexpression
    Xiong, Qiushuang, Wu, Shaoshuai, Wang, Jingwen, Zeng, Xianhuang, Chen, Jianwen, Wei, Mingcong, Guan, Haotong, Fan, Chengpeng, Chen, Lang, Guo, Deyin et al. · 2017 · Cell & Bioscience
  31. Lentivirus‑mediated microRNA‑26a overexpression in bone mesenchymal stem cells facilitates bone regeneration in bone defects of calvaria in mice
    Zhi Liu, Chang Hong, Yihong Hou, Yu Wang, Zhiqiang Zhou, Ming Wang, Zhidong Huang, Bin Yu · 2018 · Molecular Medicine Reports
  32. Biodegradable Polymers as a Noncoding miRNA Nanocarrier for Multiple Targeting Therapy of Human Hepatocellular Carcinoma
    Chengbin Yang, Ming‐Jie Yin, Gaixia Xu, Wei‐Jen Lin, Jiajie Chen, Yinling Zhang, Tao Feng, Peng Huang, Chih‐Kuang Chen, Ken‐Tye Yong · 2019 · Advanced Healthcare Materials
  33. miR-26a enhances colorectal cancer cell growth by targeting RREB1 deacetylation to activate AKT-mediated glycolysis
    Bing Chen, Yanan Deng, Xixi Wang, Zijing Xia, Yu He, Peng Zhang, Samina Ejaz Syed, Qiu Li, Shufang Liang · 2021 · Cancer Letters
  34. MicroRNA-26a–interleukin (IL)-6–IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model
    Qian He, Fei Li, Jian Li, Rui Qiang Li, G Zhan, Guang Li, W Du, Huiwen Tan · 2016 · Clinical & Experimental Immunology
  35. RETRACTED ARTICLE: microRNA-17 functions as an oncogene by downregulating Smad3 expression in hepatocellular carcinoma
    Zhufeng Lu, Xiuhua Li, Yongfeng Xu, Miaomiao Chen, Wei Chen, Tao Chen, Qinghe Tang, Zhiying He · 2019 · Cell Death and Disease · Retracted
  36. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations
    Jennifer Louten, Michael Beach, Kristina Palermino, Maria Weeks, Gabrielle Holenstein · 2015 · Biomarker Insights
  37. MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1
    Xinyu Tan, Shicai Fan, Wen Wu, Yin Zhang · 2015 · Bone Research
  38. The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects
    Motoyuki Otsuka, Takahiro Kishikawa, Takeshi Yoshikawa, Motoko Ohno, Akemi Takata, Chikako Shibata, Kazuhiko Koike · 2013 · Journal of Gastroenterology
  39. Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation
    Yi Jiang, Hong Qiong Yan, Xiao Bo Huang, Yi Nan Wang, Qing Li, FENG GUANG GAO · 2015 · Oncotarget
  40. MicroRNAs in Animal Models of HCC
    Francesca Fornari, Laura Gramantieri, Elisa Callegari, Ram Charan Shankaraiah, Fabio Piscaglia, Massimo Negrini, Catia Giovannini · 2019 · Cancers
  41. Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3/miR-34a/NF-κB in primary liver cancer.
    Yuheng Zhang, Haozhen Ren, Jun Li, Ruifeng Xue, Hanyi Liu, Zhengyi Zhu, Chen-yan Pan, Yunzhen Lin, Anyin Hu, Peng Gou et al. · 2021 · PubMed Central
  42. Role of microRNAs in hepatocellular carcinoma
    Huixiong Xu · 2015 · Frontiers in bioscience
  43. Interplay of Wnt β-catenin pathway and miRNAs in HBV pathogenesis leading to HCC
    Muhammad Adeel Rana, Bushra Ijaz, Muhammad Daud, Sommyya Tariq, Tariq Nadeem, Tayyab Husnaın · 2018 · Clinics and Research in Hepatology and Gastroenterology
  44. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1
    Jing Dong, Long Sui, QING WANG, MINGJUN CHEN, Hong Sun · 2014 · Molecular Medicine Reports
  45. MiR-26a functions as a tumor suppressor in ambient particulate matter-bound metal-triggered lung cancer cell metastasis by targeting LIN28B–IL6–STAT3 axis
    Yan-yang Lu, Yi Lin, Dong-Xiao Ding, Shu Su, Qiao-qiao Chi, Youwei Zhang, Jian Sun, Xu Zhang, Huimin Zhu, Qian-Sheng Huang et al. · 2017 · Archives of Toxicology
  46. Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells.
    Feng‐Qiang Yang, Jijiao Wang, Jiasheng Yan, Jianhua Huang, Wei Li, Jian‐Ping Che, Guangchun Wang, Min Liu, Junhua Zheng · 2014 · PubMed Central
  47. CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling
    Lixue Yang, Hui Yi Xue, Yanfu Sun, Lei Zhang, Feng Xue, Ruiliang Ge · 2020 · Cell Death and Disease
  48. Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma1
    Bo Zhu, Shaobo Chen, Xiao-Ding Hu, Xiaofeng Jin, Yichen Le, Li-Huan Cao, Zhong-Hua Yuan, Zhen Lin, Song-Min Jiang, Li-Chun Sun et al. · 2017 · Neoplasia
  49. The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma
    Suliman Khan, Deyu Zhang, Jiyu Zhang, Mian Khizar Hayat, Jingli Ren, Safyan Nasir, Muhammad Fawad, Qian Bai · 2022 · Frontiers in Oncology
  50. miR-26a attenuates colitis and colitis-associated cancer by targeting the multiple intestinal inflammatory pathways
    Wei Zhang, Xianghui Fu, Jiansheng Xie, Hongming Pan, Weidong Han, Wendong Huang · 2021 · Molecular Therapy — Nucleic Acids
  51. Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma
    Zhixia Zhou, Zhan Wang, Jie Gao, Zhijuan Lin, Yin Wang, Peipei Shan, Mengkun Li, Tingting Zhou, Peifeng Li · 2022 · Molecular Therapy — Oncolytics
  52. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma
    Wen Cheng, Chuanbao Zhang, Xiufang Ren, Yang Jiang, Sheng Han, Yang Liu, Jinquan Cai, Mingyang Li, Kuanyu Wang, Yanwei Liu et al. · 2016 · Journal of neurosurgery
  53. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A
    Shiyun Cui, Kai Zhang, Chen Li, Jing Chen, Yan Pan, Bing Feng, Lei Lü, Ziman Zhu, Rui Wang, Longbang Chen · 2016 · Oncotarget
  54. MicroRNA-1271 functions as a metastasis and epithelial-mesenchymal transition inhibitor in human HCC by targeting the PTP4A1/c-Src axis
    Chao Li, Yezhen Jiang, Runchen Miao, Kai Qu, Jingyao Zhang, Chang Liu · 2017 · International Journal of Oncology
  55. Evaluation of MicroRNAs Regulating Anoikis Pathways and Its Therapeutic Potential
    Sharan Malagobadan, Noor Hasima Nagoor · 2015 · BioMed Research International
  56. KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway
    H Li, Xiuli Jiang, Dou Yu, Wenwei Huang, H Xing, Nathalie Y.R. Agar, Yang Hw, Bing Yang, Rona Stephanie Carroll, Johnson · 2014 · Oncogene
  57. Upregulation of Tubulointerstitial nephritis antigen like 1 promotes gastric cancer growth and metastasis by regulating multiple matrix metallopeptidase expression
    Zhi‐guo Shan, Zhen‐Wei Sun, Liqun Zhao, Qiang Gou, Zhi‐Fu Chen, Jinyu Zhang, Weisan Chen, Su Chongyu, Nan You, Yuan Zhuang et al. · 2020 · Journal of Gastroenterology and Hepatology
  58. miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19
    Brandon Bautista-Becerril, Guillermo Pérez-Dimas, Paola C. Sommerhalder-Nava, Alejandro Hanono, Julio A. Martínez-Cisneros, Bárbara Zarate-Maldonado, Evangelina Muñoz-Soria, Arnoldo Aquino‐Gálvez, Manuel de Jesús Castillejos-López, Armida Juárez-Cisneros et al. · 2021 · Viruses
  59. Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
    Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, Moein Ala · 2023 · Biomedicine & Pharmacotherapy
  60. MicroRNA‑140‑5p suppresses cell proliferation and invasion in gastric cancer by targeting WNT1 in the WNT/β‑catenin signaling pathway
    Yinlian Cha, Ying He, Kaobin Ouyang, Hailin Xiong, Jun Li, Xia Yuan · 2018 · Oncology Letters
  61. MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance
    Ulrich H. Weidle, DANIELA SCHMID, Fabian Birzele, Ulrich Brinkmann · 2019 · Cancer Genomics & Proteomics
  62. AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo
    Ling Yin, Geoffrey D. Keeler, Yuanhui Zhang, Brad E. Hoffman, Chen Ling, Keyun Qing, Arun Srivastava · 2020 · Gene Therapy
  63. Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression
    Yulin Sun, Fubo Ji, Mia R. Kumar, Xin Min Zheng, Yi Xiao, Niya Liu, Jiong Shi, Linda L. Wong, Marshonna Forgues, Lun–Xiu Qin et al. · 2017 · International Journal of Biological Sciences
  64. A P53‐related microRNA model for predicting the prognosis of hepatocellular carcinoma patients
    Shuangsang Fang, Jincheng Guo, Jianhua Zhang, Jin‐Na Liu, Shuai Hong, Bo Yu, Yuhan Gao, Supei Hu, Hai‐Zhong Liu, Liang Dan Sun et al. · 2019 · Journal of Cellular Physiology
  65. MicroRNA-26a modulates transforming growth factor beta-1-induced proliferation in human fetal lung fibroblasts
    Xiaoou Li, Lian Liu, Yongchun Shen, Tao Wang, Lei Chen, Dan Xu, Fuqiang Wen · 2014 · Biochemical and Biophysical Research Communications
  66. Circulating microRNAs as potential non-invasive biomarkers for the early detection of hypertension-related stroke
    Weizhong Li, Jun Jang Jin, Jiaping Chen, Yue-qin Guo, Jiulai Tang, S Tan · 2013 · Journal of Human Hypertension
  67. MiR‐106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain‐containing protein 7A (Zbtb7a)
    Xiao Liang, Qinghua Zhao, Tingting Geng, Shengshu Luo, Qin He · 2018 · Journal of Biochemical and Molecular Toxicology
  68. Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
    Lucilla D’Abundo, Elisa Callegari, Antonella Bresin, Antonella Chillemi, Bahaeldin K. Elamin, Paola Guerriero, Xiaomeng Huang, Elena Saccenti, E M A A Hussein, Fabio Casciano et al. · 2017 · Oncogene
  69. Regulatory role of miRNA‑26a in neonatal sepsis
    Qi Cheng, Lili Tang, Yibiao Wang · 2018 · Experimental and Therapeutic Medicine
  70. Emerging roles and potential clinical applications of noncoding RNAs in hepatocellular carcinoma
    Pengbo Cao, Qian Jin, Lan Feng, Haibei Li, Geng Qin, Gangqiao Zhou · 2020 · Seminars in Cancer Biology
  71. Early Life Ozone Exposure Results in Dysregulated Innate Immune Function and Altered microRNA Expression in Airway Epithelium
    Candice C. Clay, Kinjal M. Hew, Joan E. Gerriets, Theodore T. Wang, Edward M. Postlethwait, Michael J. Evans, Justin H. Fontaine, Lisa A. Miller · 2014 · PLoS ONE
  72. Role of microRNAs in inflammation-associated liver cancer
    Lin Huan, Linhui Liang, Xianghuo He · 2016 · Cancer Biology and Medicine
  73. Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
    Soon Sun Kim, Hyo Jung Cho, Ji Sun Nam, Hyun Ji Kim, Dae Ryong Kang, Je Hwan Won, Jinoo Kim, Jai Keun Kim, Jei Hee Lee, Bo Hyun Kim et al. · 2017 · Journal of Korean Medical Science
  74. miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma
    Suling Chen, Fang Li, Hai-yun Chai, Xin Tao, Haili Wang, Aifang Ji · 2015 · Biochemical and Biophysical Research Communications
  75. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study
    Liang Liang, Jiang‐Hui Zeng, Jieyu Wang, Rong‐Quan He, Jie Ma, Gang Chen, Xiaoyong Cai, Xiaohua Hu · 2017 · Pathology - Research and Practice
  76. Signal transducer and activator of transcription 1 (STAT1) acts like an oncogene in malignant pleural mesothelioma
    L. Arzt, Hannelore Kothmaier, I. Halbwedl, F. Quehenberger, H. Popper · 2014 · Virchows Archiv
  77. MicroRNA-30b Suppresses Epithelial-Mesenchymal Transition and Metastasis of Hepatoma Cells
    Xiaolin Sun, Shuhua Zhao, Huanan Li, Hanwen Chang, Zhen Dong Huang, Zhi Ding, Lei Dong, Jiangning Chen, Yuhui Zang, Junfeng Zhang · 2016 · Journal of Cellular Physiology
  78. Association between the expression levels of IL‑6 and IL‑6R in the hepatocellular carcinoma microenvironment and postoperative recurrence
    Mao Zhang, Shun Zhang, Zhenjie Yang, Jie Hu, Weiyu Hu, Peng Sun, Liqun Wu, Bing Han · 2018 · Oncology Letters
  79. Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
    Lisa Linck-Paulus, Claus Hellerbrand, Anja‐Katrin Bosserhoff, Peter Dietrich · 2020 · Cells
  80. Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application
    Ling Yin, Hongliang He, Hongliang Zhang, Yuhua Shang, Chengbo Fu, Songquan Wu, Tengchuan Jin · 2025 · Journal of Medical Virology
  81. Effect of miR‑140‑5p on the regulation of proliferation and apoptosis in NSCLC and its underlying mechanism
    Wenwen Zhou, Xiaoyu Wang, Duanduan Yin, Lei Xue, Zhongfeng Ma, Zhenzhen Wang, Qianyi Zhang, Zishu Zhao, Haixia Wang, Yan Sun et al. · 2019 · Experimental and Therapeutic Medicine
  82. miR-363-5p as potential prognostic marker for hepatocellular carcinoma indicated by weighted co-expression network analysis of miRNAs and mRNA
    Jun Zhang, Jia Fan, Chongming Zhou, Yanyu Qi · 2017 · BMC Gastroenterology
  83. Hepatitis B virus‐regulated growth of liver cancer cells occurs through the microRNA‐340‐5p‐activating transcription factor 7‐heat shock protein A member 1B axis
    Feifei Song, M. Wei, Jingwen Wang, Yang Liu, Ming-Xiong Guo, Xiaolu Li, Jun Luo, Jun-Ying Zhou, Min Wang, De-Yin Guo et al. · 2019 · Cancer Science
  84. MiR-26a Reduces Inflammatory Responses via Inhibition of PGE2 Production by Targeting COX-2
    Ting Yu, Peng Wang, Yuxia Wu, Jingbo Zhong, Qingshu Chen, Daimei Wang, Hong Chen, Shengfeng Hu, Qiongshi Wu · 2022 · Inflammation
  85. Metformin induces apoptosis by microRNA-26a-mediated downregulation of myeloid cell leukaemia-1 in human oral cancer cells
    Fang Wang, Jincheng Xu, HAO LIU, Zhe Liu, FEI XIA · 2016 · Molecular Medicine Reports
  86. Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma
    Chuan Tian, Shanshan Yao, Li Liu, Youcheng Ding, Qingwang Ye, Xiao Dong, Yong Gao, Ning Yang, Qi Li · 2016 · International Journal of Molecular Medicine
  87. Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma
    Min Yao, Li Wang, Yao Yao, Hong-Bing Gu, Dengfu Yao · 2014 · Journal of Clinical and Translational Hepatology
  88. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats
    Mohamed Fatehy Hassan Balaha, Samah Kandeel, Waleed Barakat · 2016 · Toxicology and Applied Pharmacology
  89. Molecular mechanisms of oncogene-induced inflammation and inflammation-sustained oncogene activation in gastrointestinal tumors: An underappreciated symbiotic relationship
    Denada Dibra, Lopa Mishra, Shulin Li · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  90. KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite
    Minako Ikoma, Soren M. Gantt, Corey Casper, Yuko Ogata, Qing Zhang, Ryan Basom, Michael R. Dyen, Timothy M. Rose, Serge Barcy · 2018 · PLoS ONE
  91. Cell differentiation-related signaling pathways in hepatocellular carcinoma metastasis
    Ze Xiang, Jiarui Li, Yunyang Xu, Chenhao Xu, Shusen Zheng, Jian Chen, Xuyong Wei, Xiao Xu · 2025 · Cancer Letters
  92. The role of circulating microRNA in hepatocellular carcinoma
    Christopher Christophi · 2015 · Frontiers in bioscience
  93. Concentration of circulating miRNA-containing particles in serum enhances miRNA detection and reflects CRC tissue-related deregulations
    Abdou ElSharawy, Christian Röder, Thomas Becker, Jens Karsten Habermann, Stefan Schreiber, Philip C Rosenstiel, Holger Kalthoff · 2016 · Oncotarget
  94. microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma
    Xiaomei Gao, Ying Zhu, Jianhua Li, Xiangyu Wang, Xiaofei Zhang, Chenhe Yi, Xin Ling Yang · 2018 · OncoTargets and Therapy
  95. Prospects of Noncoding RNAs in Hepatocellular Carcinoma
    Huaixiang Zhou, Qiuran Xu, Chao Ni, Song Ye, Xiaowu Xu, Xiaoge Hu, Jiahong Jiang, Yeting Hong, Dongsheng Huang, Liu Yang · 2018 · BioMed Research International
  96. Systematic review of the roles of interleukins in hepatocellular carcinoma
    Yang Hu, Yang Xuefeng, Xiao Jianhua · 2020 · Clinica Chimica Acta
  97. Glutathione-s-transferase A 4 (GSTA4) suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting AKT pathway.
    Chang Jun Liu, Jin Hui Yang, Fei Huang, Wanpin Nie, Chu Ping Liu, X H Mao, Xin Yin, Xian Bo Shen, Chuang Peng, Mei Fu Chen et al. · 2017 · Europe PMC (PubMed Central)
  98. miR‐26a modulates HGF and STAT3 effects on the kidney repair process in a glycerol‐induced AKI model in rats
    Pedro Paulo Gattai Gomes, Edgar Maquigussa, Antonio da Silva Novaes, Rosemara Silva Ribeiro, Vanessa Araújo Varela, Milene Subtil Ormanji, Mírian Aparecida Boim · 2018 · Journal of Cellular Biochemistry
  99. MicroRNA-506 suppresses invasiveness and metastasis of human hepatocellular carcinoma cells by targeting IL8.
    Zhuo Wang, Mahui Si, Ning Yang, Haibin Zhang, Yong Fu, Kai Yan, Yi Zong, Nan Zhu, Yongpeng Wei · 2018 · PubMed Central
  100. Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma
    Xiao-Fei Zhang, Ji Wang, Hu‐Liang Jia, Wenwei Zhu, Lu Lu, Qing‐Hai Ye, Peter Jon Nelson, Yi Qin, Dongmei Gao, Hai-Jun Zhou et al. · 2019 · Cell Death Discovery